The inhibitor of 20-HETE synthesis, TS-011, improves cerebral microcirculatory autoregulation impaired by middle cerebral artery occlusion in mice

Br J Pharmacol. 2010 Nov;161(6):1391-402. doi: 10.1111/j.1476-5381.2010.00973.x.

Abstract

Background and purpose: 20-Hydroxyeicosatetraenoic acid is a potent vasoconstrictor that contributes to cerebral ischaemia. An inhibitor of 20-Hydroxyeicosatetraenoic acid synthesis, TS-011, reduces infarct volume and improves neurological deficits in animal stroke models. However, little is known about how TS-011 affects the microvessels in ischaemic brain. Here, we investigated the effect of TS-011 on microvessels after cerebral ischaemia.

Experimental approach: TS-011 (0.3 mg·kg(-1) ) or a vehicle was infused intravenously for 1 h every 6 h in a mouse model of stroke, induced by transient occlusion of the middle cerebral artery occlusion following photothrombosis. The cerebral blood flow velocity and the vascular perfusion area of the peri-infarct microvessels were measured using in vivo two-photon imaging.

Key results: The cerebral blood flow velocities in the peri-infarct microvessels decreased at 1 and 7 h after reperfusion, followed by an increase at 24 h after reperfusion in the vehicle-treated mice. We found that TS-011 significantly inhibited both the decrease and the increase in the blood flow velocities in the peri-infarct microvessels seen in the vehicle-treated mice after reperfusion. In addition, TS-011 significantly inhibited the reduction in the microvascular perfusion area after reperfusion, compared with the vehicle-treated group. Moreover, TS-011 significantly reduced the infarct volume by 40% at 72 h after middle cerebral artery occlusion.

Conclusions and implications: These findings demonstrated that infusion of TS-011 improved defects in the autoregulation of peri-infarct microcirculation and reduced the infarct volume. Our results could be relevant to the treatment of cerebral ischaemia.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Flow Velocity / drug effects
  • Blood Flow Velocity / physiology
  • Brain Ischemia / drug therapy
  • Brain Ischemia / etiology
  • Brain Ischemia / physiopathology
  • Cerebrovascular Circulation / drug effects*
  • Cerebrovascular Circulation / physiology
  • Disease Models, Animal
  • Formamides / administration & dosage*
  • Formamides / therapeutic use*
  • Homeostasis / drug effects*
  • Homeostasis / physiology
  • Hydroxyeicosatetraenoic Acids / antagonists & inhibitors*
  • Hydroxyeicosatetraenoic Acids / biosynthesis*
  • Infarction, Middle Cerebral Artery / drug therapy*
  • Infarction, Middle Cerebral Artery / etiology
  • Infarction, Middle Cerebral Artery / physiopathology
  • Infusions, Intravenous
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microcirculation / drug effects
  • Microcirculation / physiology
  • Morpholines / administration & dosage*
  • Morpholines / therapeutic use*

Substances

  • Formamides
  • Hydroxyeicosatetraenoic Acids
  • Morpholines
  • N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide
  • 20-hydroxy-5,8,11,14-eicosatetraenoic acid